These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12497995)

  • 1. [Clinico-immunological comparisons in evaluation of interferon system functioning in patients with multiple sclerosis].
    Kobiakina NA; Chekneva NS; Mezentseva MV; Narovlianskiĭ AN; Cheknev SB; Skvortsova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(11):38-42. PubMed ID: 12497995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between interferon production and clinical disease activity in patients with multiple sclerosis.
    Dettke M; Scheidt P; Prange H; Kirchner H
    J Clin Immunol; 1997 Jul; 17(4):293-300. PubMed ID: 9258768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between interferon priming effect and functional activity of human blood cells].
    Cheknev SB; Amchenkova AM; Narovlianskiĭ AN
    Vopr Virusol; 2002; 47(2):40-2. PubMed ID: 12046468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.
    Braakman E; van Tunen A; Meager A; Lucas CJ
    Clin Exp Immunol; 1986 Nov; 66(2):285-94. PubMed ID: 2949897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between in vitro effects of preparations of interferon and its inducers on blood cells in patients with multiple sclerosis.
    Cheknev SB; Mezentseva MV; Narovlyansky AN; Kobyakina NA; Ershov FI
    Bull Exp Biol Med; 2001 Apr; 131(4):382-4. PubMed ID: 11550032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular sensitivity to the effect of interferon during different forms of viral pathology].
    Narovlianskiĭ AN; Amchenkova AM; Mezentseva MV; Ershov FI
    Vopr Virusol; 2000; 45(3):20-5. PubMed ID: 10867990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IL-2, IFN-gamma, and TNF-alpha mRNA expression in peripheral blood mononuclear cells in patients with multiple sclerosis].
    Lin J; Li L; Gao Y; Min B; Xu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Feb; 19(1):24-8. PubMed ID: 10453548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
    Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of prostaglandin E2 and indomethacin on interferon-gamma production by cultured peripheral blood leukocytes of multiple sclerosis patients and healthy donors.
    Vervliet G; Deckmyn H; Carton H; Billiau A
    J Clin Immunol; 1985 Mar; 5(2):102-8. PubMed ID: 3921560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis.
    Lu CZ; Jensen MA; Arnason BG
    J Neuroimmunol; 1993 Jul; 46(1-2):123-8. PubMed ID: 7689582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon production and natural killer activity of peripheral blood lymphocytes obtained from patients with multiple sclerosis].
    Maruo Y
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):521-33. PubMed ID: 2464533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon production in peripheral blood cells of patients with pulmonary mycobacterial disease].
    Tada A; Kawahara S; Tamaoki A; Takeuchi M; Tanimoto Y; Okada C; Mishima Y; Soda R; Takahashi K; Kibata M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Feb; 33(2):114-9. PubMed ID: 7731113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients.
    Pentón-Rol G; Cervantes-Llanos M; Cabrera-Gómez JA; Alonso-Ramírez R; Valenzuela-Silva C; Rodríguez-Lara R; Montero-Casimiro E; Bello-Rivero I; López-Saura P
    Int Immunopharmacol; 2008 Jun; 8(6):881-6. PubMed ID: 18442793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseases.
    Vervliet G; Carton H; Billiau A
    Clin Exp Immunol; 1985 Feb; 59(2):391-7. PubMed ID: 3919978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in PBMC-produced IFN-γ and TNF-α associations with relapse in multiple sclerosis.
    Zhou Y; Taylor B; van der Mei I; Stewart N; Charlesworth J; Blizzard L; Ponsonby AL; Dwyer T; Pittas F; Simpson S
    J Neurol Sci; 2015 Feb; 349(1-2):40-4. PubMed ID: 25575858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mitogen- and virus-induced interferon production in whole blood cell cultures of patients with various solid carcinomas and controls.
    Elsässer-Beile U; von Kleist S; Martin M
    Tumour Biol; 1992; 13(5-6):358-63. PubMed ID: 1290032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased interferon-α production in response to CpG DNA dysregulates cytokine responses in patients with multiple sclerosis.
    Hirotani M; Niino M; Fukazawa T; Yaguchi H; Nakamura M; Kikuchi S; Sasaki H
    Clin Immunol; 2012 May; 143(2):145-51. PubMed ID: 22386492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal variation of interferon-gamma production in progressive multiple sclerosis.
    Balashov KE; Olek MJ; Smith DR; Khoury SJ; Weiner HL
    Ann Neurol; 1998 Nov; 44(5):824-8. PubMed ID: 9818941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.